As FDA shortages lift, patients and physicians explore new options for continued treatment with compounded GLP-1 medications.

A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...

Growth hormone injections deliver a synthetic growth hormone to the body to treat hormone deficiencies and other health ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

More than 1000 people -- shoulder-to-shoulder in bleachers, on the ground and on folding chairs -- jammed the Clackamas ...

While the idea may not appeal to needle-phobics, a growing number of people are exploring injectables as a way of improving ...

SAN DIEGO -- Two retrospective studies hinted at potential negative effects of GLP-1 receptor agonists for patients requiring ...

Ozempic (generic name: semaglutide) is a prescription medication used primarily to manage type 2 diabetes and assist with ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

The company’s weight loss therapy was able to sustain itself for up to 40 days in obese patients after a single injection.

Scientists have discovered a naturally-occurring molecule that rivals the weight-loss effects of semaglutide-based GLP-1s like Ozempic in animals.